Form 4: Director Steve Krognes Exercises Guardant Health RSUs

Director Steve Krognes acquired 154 shares of Guardant Health common stock through the vesting of restricted stock units.

Summary

• Director Steve Krognes acquired 154 shares of Guardant Health (GH) common stock on May 31, 2026.
• The acquisition resulted from the vesting of restricted stock units (RSUs) granted on August 9, 2022.
• Following the transaction, the director holds a total of 19,516 shares of common stock directly.
• The transaction involved no cash consideration as the shares were acquired upon the vesting of previously granted equity awards.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative transaction related to pre-existing director compensation agreements.

Positives

• Director maintains a significant equity stake of 19,516 shares, aligning interests with shareholders.

Negatives

• None identified; this is a routine equity compensation vesting event.

Risks

• None identified; this is a standard administrative filing regarding director compensation.

Future Outlook

The remaining 75% of the original RSU award continues to vest in substantially equal monthly installments over the three-year period following the initial vesting date.

Management Comments

• The transaction reflects the standard vesting schedule of an equity award granted in 2022.

Industry Context

StockSavvy.ai notes that routine RSU vesting for directors is a standard corporate governance practice in the biotechnology and healthcare sectors, indicating no change in strategic direction or insider sentiment.

Comparison to Industry Standards

• The transaction is consistent with standard executive and director compensation structures in the life sciences industry.
• The reporting of equity movements via Form 4 is a standard regulatory requirement for all publicly traded companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Continued monthly vesting of the remaining RSU balance.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Trading, Director Compensation, Equity Vesting